FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 4.0.1  |  FHIR Version n/a  User: [n/a]

332402005: Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
468799014 Cyproterone acetate+ethinyloestradiol 2mg/35micrograms tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
468800013 Co-cyprindiol 2mg/35mcg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
468801012 Cyproterone acetate+ethinylestradiol 2mg/35micrograms tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
721685017 Cyproterone acetate+ethinylestradiol 2mg/35micrograms tablet (substance) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
1192757016 Cyproterone acetate+ethinylestradiol 2mg/35micrograms tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2463733016 Cyproterone acetate+ethinylestradiol 2000mcg/35micrograms tablet (product) en Fully specified name Inactive Only initial character case insensitive SNOMED CT core module
2469019018 Cyproterone acetate+ethinyloestradiol 2000mcg/35micrograms tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
2469500015 Cyproterone acetate+ethinylestradiol 2000mcg/35micrograms tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
2476630019 Co-cyprindiol 2000mcg/35mcg tablet en Synonym Inactive Only initial character case insensitive SNOMED CT core module
3474088019 Cyproterone acetate 2 mg and ethinyl estradiol 0.035 mg oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3474089010 Cyproterone acetate 2 mg and ethinylestradiol 0.035 mg oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3474090018 Product containing cyproterone acetate 2 milligram and ethinylestradiol 0.035 milligram/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3474091019 Product containing cyproterone acetate 2 milligram and ethinyl estradiol 0.035 milligram/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3484741017 Product containing cyproterone acetate 2 milligram and ethinylestradiol 0.035 milligram/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3567459014 Product containing only cyproterone acetate 2 milligram and ethinylestradiol 0.035 milligram/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3567460016 Product containing only cyproterone acetate 2 milligram and ethinylestradiol 0.035 milligram/1 each oral tablet (clinical drug) en Fully specified name Inactive Entire term case insensitive SNOMED CT core module
3567461017 Product containing only cyproterone acetate 2 milligram and ethinyl estradiol 0.035 milligram/1 each oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3699591011 Cyproterone acetate 2 mg and ethinyl estradiol 35 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3699592016 Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet en Synonym Inactive Entire term case insensitive SNOMED CT core module
3699593014 Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3699594015 Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
46773601000001114 Co-cyprindiol 2000microgram/35microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

30 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Product containing cyproterone acetate and ethinyl estradiol false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Cyproterone false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Hormone false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Hormones and their metabolites and precursors false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Estradiol false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Product containing estradiol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has basis of strength substance Cyproterone acetate true Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has basis of strength substance Cyproterone acetate false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has basis of strength substance Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator value 35 false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator value 2 false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator value 0.035 false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator value 2 false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has precise active ingredient Cyproterone acetate false Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Plays role Contraceptive therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Plays role Antiacne therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has precise active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has presentation strength numerator unit microgram true Inferred relationship Existential restriction modifier 1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has precise active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier 2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Ethinylestradiol false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has active ingredient Cyproterone false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Count of base of active ingredient 2 false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has specific active ingredient Cyproterone acetate true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has specific active ingredient Ethinylestradiol true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Is a Co-cyprindiol true Inferred relationship Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Cyproterone acetate+ethinyloestradiol 2mg/35micrograms tablet - product Is a False Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (CST Pharma Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (Schering Health Care Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (PI) (Dowelhurst Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (PI) (Waymade Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Unichem Plc) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (A A H Pharmaceuticals Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Acnocin 2000microgram/35microgram tablets (Sandoz Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Diva 2000/35 tablets (Zeroderma Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Zentiva Pharma UK Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (CST Pharma Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Somex Pharma) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 63 tablet Is pack of False Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Clairette 2000/35 tablets (Kent Pharma (UK) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (Viatris UK Healthcare Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Medihealth (Northern) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (PLIVA Pharma Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Is pack of False Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Almus Pharmaceuticals Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Ranbaxy (UK) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (Sigma Pharmaceuticals Plc) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Sigma Pharmaceuticals Plc) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 63 tablet Has VMP True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet Has VMP True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (Lexon (UK) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Phoenix Healthcare Distribution Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Fannin (UK) Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Dianette tablets (Mawdsley-Brooks & Company Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Waymade Healthcare Plc) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Doncaster Pharmaceuticals Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd) Is a True Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start